A randomized clinical trial of quetiapine to reduce post-concussive syndrome polypharmacy

Active Project Grant Awarded

Award ID
HT94252310829
Recipient
Awarding agency
Obligated
$2,140,031

Award facts

Assistance listing
12.420 Military Medical Research and Development
Completion date 81% complete
Place of performance
San Antonio, TX 78229, USA

Award details come from USAspending.gov.

Subawards

Subrecipient Amount Awarded
Biomedical Research Institute Of New Mexico To conduct a clinical trial to evaluate the effectiveness of Quetiapine monotherapy vs Treatment as Usual to reduce post concussive symptoms $167,918
The University Of Texas Health Science Center At San Antonio Conduct clinical trial to evaluate the effectiveness of Quetiapine monotherapy vs Treatment as Usual to reduce postconcussive symptoms $194,124

Quick answers

Who received award HT94252310829?

HT94252310829 was awarded to Foundation For Advancing Veterans Health Research by Defense Health Agency (Department of Defense) on August 16, 2023.

How much is award HT94252310829 worth?

$2,140,031 has been obligated on HT94252310829.

On GovTribe

See this award's full record

  • Every transaction and subaward
  • The recipient's other awards and teaming partners
  • Similar grant awards
  • Ask GovTribe AI about this award